Hong Luo

Active 1996–2026

546
Papers
31,081
Citations
91
h-index
360
i10-index

Citations

Citations per year for Hong Luo1976: 1 citations1980: 1 citations1985: 1 citations1990: 1 citations1991: 1 citations1997: 12 citations1998: 32 citations1999: 75 citations2000: 85 citations2001: 68 citations2002: 76 citations2003: 75 citations2004: 71 citations2005: 74 citations2006: 62 citations2007: 71 citations2008: 76 citations2009: 86 citations2010: 136 citations2011: 117 citations2012: 144 citations2013: 150 citations2014: 194 citations2015: 177 citations2016: 221 citations2017: 224 citations2018: 307 citations2019: 642 citations2020: 929 citations2021: 1,246 citations2022: 1,208 citations2023: 991 citations2024: 1,694 citations2025: 940 citations2026: 82 citations1977–1979: no citations, so these years are not shown1981–1984: no citations, so these years are not shown1986–1989: no citations, so these years are not shown1992–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 3,788 citing papers, 27.4% of this breakdownUnited States: 2,581 citing papers, 18.7% of this breakdownUnited Kingdom: 601 citing papers, 4.4% of this breakdownGermany: 489 citing papers, 3.6% of this breakdownIndia: 486 citing papers, 3.5% of this breakdownItaly: 431 citing papers, 3.1% of this breakdownAustralia: 334 citing papers, 2.4% of this breakdownFrance: 334 citing papers, 2.4% of this breakdownCanada: 323 citing papers, 2.3% of this breakdownSpain: 318 citing papers, 2.3% of this breakdownSouth Korea: 312 citing papers, 2.3% of this breakdownJapan: 254 citing papers, 1.8% of this breakdown
0%27.4%Other 25.8%

Fields

  • Medicine34.2%
  • Biochemistry, Genetics and Molecular Biology22.7%
  • Computer Science15.7%
  • Engineering9.2%
  • Agricultural and Biological Sciences5.4%
  • Immunology and Microbiology3.1%
  • Other9.7%

Topics

  • Long-Term Effects of COVID-192%
  • COVID-19 Clinical Research Studies1.8%
  • CAR-T cell therapy research1.7%
  • Protein Hydrolysis and Bioactive Peptides1.5%
  • IoT and Edge/Fog Computing1.2%
  • Energy Efficient Wireless Sensor Networks1.1%
  • Other90.7%

Coauthors

All papers

Open in search
  1. Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits lung cancer cell growth and migration via calcium/calmodulin-dependent ferroptosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Zuyi Yang, Huifen Tang, Tian Xie, Xiaoping Ouyang, Xinbing Sui - Signal Transduction and Targeted Therapy 2020 cited by 429

  2. Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Howard Gurney, Elizabeth Hovey, Anthony M. Joshua, Matos Marco, Gavin Marx, Michelle Morris, Siobhan Ng, David Pook, Shahneen Sandhu, Ali Tafreshi, Thean Hsiang Tan, Tsvetanka Tosheva, Livia Andrade, Felipe Melo Cruz, Luiza Dib Batista Bugiato Faria, J. M. L. Figueiredo, Fábio Franke, Andrea Juliana Gomes, Ariel Galapo Kann, Celio Kussumoto, Suelen Patrícia dos Santos Martins, André M. Murad, Hélio Pinczowski, Giovani Thomaz Pioner, Luís Ferreira Pires, Daniel D’Almeida Preto, Gisele Marinho dos Santos, Eduardo Silva, Jamile Silva, Luciano de Souza Viana, Karina Vianna, Adriano Augusto Peclat de Paula, Zhiwen Chen, Kim Chi, Urban Emmenegger, Neil Fleshner, Sunil Parimi, Fred Saad, Francisco Vera-Badillo, Hongqian Guo, Hong Luo, Lulin Ma, Mingxing Qui, Wei Xue, Guo Yonglian, Lei Li, Jinxian Pu, Song Zheng, Qing Zou, Miloš Broďák, Milan Hora, Vladimír Šámal, Vladimír Študent, J Vaňásek, Emmanuelle Bompas, Philippe Barthélémy, Delphine Borchiellini, Aude Fléchon, Hakim Mahammedi, Guilhem Roubaud, Antoine Thiery-Vuillemin, Diégo Tosi, Dominique Spaëth, Carole Hélissey, Martin Boegemann, Susan Feyerabend, Eva Hellmis, Martin Schostak, Gerhardt Attard, Anna Lydon and 141 more - Journal of Clinical Oncology 2023 cited by 319

  3. Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Romanee Chaiwarith, Methee Chayakulkeeree, Sharon Chen, Yee‐Chun Chen, Yen‐Hsu Chen, Jun Yong Choi, Young Hwa Choi, Darunee Chotiprasitsakul, Jin-Won Chung, François Danion, Blandine Denis, Emilio Diaz Santos, Miguel O Dictar, Marc Diltoer, Hervé Dupont, Sizhou Feng, Maria Angeles Ferre Colomer, Ricard Ferrer, Jean-Marie Fernand Roger Forel, Jesús Fortün, Julia Garcia‐Diaz, Massimo Girardis, Fang He, Maya Hites, Mao‐Wang Ho, Patrick M. Honoré, Juan Pablo Horcajada, Haihui Huang, Po‐Yen Huang, Yong Huang, Osamah Hussein, Poj Intalapaporn, Sutep Jaruratanasirikul, Luis Jáuregui-Peredo, Misty Johnson, Dong Sik Jung, Kamonwan Jutivorakool, Winfried V. Kern, Daniel H. Kett, Thana Khawcharoenporn, Young Keun Kim, Philipp Koehler, Αναστασία Κοτανίδου, Anne M. Lachiewicz, Qinhan Lin, Luis Eduardo López Cortés, Hong Luo, Roberto Luzzati, ‪Yasmin Maor‬‏, Todd P McCarty, Maria Merelli, Paloma Merino Amador, John Midturi, Guglielmo Marco Migliorino, Jean‐Paul Mira, Piroon Mootsikapun, Orla Morrissey, Patricia Muñoz García de Paredes, Cristina Mussini, Eleftherios Mylonakis, Saadalla Nseir, William Nseir, Zekaver Odabaşı, Vasileios Papastamopoulos, David L. Paterson, Thomas F. Patterson, Kyong Ran Peck, Zhiyong Peng, Nitipong Permpalung, Gaëtan Plantefève and 42 more - The Lancet 2022 cited by 168

  4. Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody–Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2020 cited by 281

  5. Computation Offloading and Resource Allocation in NOMA-MEC: A Deep Reinforcement Learning Approach

    Authors: , , , - IEEE Internet of Things Journal, IEEE Internet Things J. 2023 cited by 74

  6. Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2–Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis of Two Phase II Clinical Trials

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 cited by 156

  7. Coexpression of IL7 and CCL21 Increases Efficacy of CAR-T Cells in Solid Tumors without Requiring Preconditioned Lymphodepletion

    Authors: , , , , , , , , - Clinical Cancer Research 2020 cited by 179

  8. ESE

    Authors: , , , , , , , , , , , - ACM/SIGDA International Symposium on Field-Programmable Gate Arrays, Proceedings of the 2017 ACM/SIGDA International Symposium on Field-Programmable Gate Arrays 2017 cited by 595

  9. Novel angiotensin-converting enzyme inhibitory peptides from tuna byproducts—milts: Preparation, characterization, molecular docking study, and antioxidant function on H2O2-damaged human umbilical vein endothelial cells

    Authors: , , , , - Frontiers in Nutrition 2022 cited by 100

  10. Extensive variation within the pan-genome of cultivated and wild sorghum

    Authors: , , , , , , , , , , , , - Nature Plants 2021 cited by 237

  11. Olaparib Suppresses MDSC Recruitment via SDF1α/CXCR4 Axis to Improve the Anti-tumor Efficacy of CAR-T Cells on Breast Cancer in Mice

    Authors: , , , , , , , , , , - Molecular Therapy 2020 cited by 120

  12. Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma

    Authors: , , , , , , , , , , , - Frontiers in Pharmacology 2018 cited by 205

  13. Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma

    Authors: , , , , , , , , , - Molecular Therapy 2017 cited by 185

  14. CXCR4-modified CAR-T cells suppresses MDSCs recruitment via STAT3/NF-κB/SDF-1α axis to enhance efficacy against pancreatic cancer

    Authors: , , , , , , , , , , - Molecular Therapy 2023 cited by 86

  15. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery

    Authors: , , , , , , , , , , , , - EClinicalMedicine 2020 cited by 974

  16. Dysregulation of Ubiquitin-Proteasome System in Neurodegenerative Diseases

    Authors: , , , , , , - Frontiers in Aging Neuroscience 2016 cited by 311

  17. Extensive sampling of basidiomycete genomes demonstrates inadequacy of the white-rot/brown-rot paradigm for wood decay fungi

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 750

  18. Combined Antitumor Effects of Sorafenib and GPC3-CAR T Cells in Mouse Models of Hepatocellular Carcinoma

    Authors: , , , , , , , , , - Molecular Therapy 2019 cited by 157

  19. β2-Microglobulin coaggregates with Aβ and contributes to amyloid pathology and cognitive deficits in Alzheimer’s disease model mice

    Authors: , , , , , , , , , , , , , , , , - Nature Neuroscience 2023 cited by 74

  20. Alterations in the human oral and gut microbiomes and lipidomics in COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Gut 2021 cited by 298

  21. Persistent white matter changes in recovered COVID-19 patients at the 1-year follow-up

    Authors: , , , , , , , , , , , , , , , , , - Brain 2021 cited by 107

  22. Armored Inducible Expression of IL-12 Enhances Antitumor Activity of Glypican-3–Targeted Chimeric Antigen Receptor–Engineered T Cells in Hepatocellular Carcinoma

    Authors: , , , , , , , , , - The Journal of Immunology 2019 cited by 140

  23. A Randomized, Open‐Label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID‐19, a Pilot Study

    Authors: , , , , , , , , , , , , , , , , , , , , , - Advanced Science 2020 cited by 179

  24. Management of granulomatous lobular mastitis: an international multidisciplinary consensus (2021 edition)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wenjie Dai, Zhi-Jun Dai, Qinyu Feng, Qingjun Gao, Runfang Gao, Baosan Han, Jinxuan Hou, Wei Hou, Haiying Liao, Hong Luo, Zhengren Liu, Jing-Hua Lu, Bin Luo, Xiaopeng Ma, Jun Qian, Jian-Yong Qin, Wei Wei, Gang Wei, Liying Xu, Hui-Chao Xue, Huawei Yang, Weige Yang, Chaojie Zhang, Fan Zhang, Guanxin Zhang, Shaokun Zhang, Shu-Qun Zhang, Ye-Qiang Zhang, Yuepeng Zhang, Sheng-Chu Zhang, Daiwei Zhao, Xiang-Min Zheng, Lewei Zheng, Gaoran Xu, Wenbo Zhou, Gaosong Wu - Military Medical Research 2022 cited by 140